stock
SRPT · Sarepta Therapeutics, Inc.
What Sarepta Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live SRPT price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on SRPT.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 105,627,021 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -9.7%
- Net
- -9.3%
Returns
- ROE
- -8.9%
- ROA
- -4.3%
Health
- Current ratio
- 4.4x
- Debt/equity
- 0.6x
Deep value
- NCAV
- $563.11M
- NCAV per share
- $5.33
- Price/NCAV
- Locked
- NNWC
- -$354.81M
- NNWC per share
- -$3.36
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $328.69M | — | $13.29M | -$4.89M | 10-Q filed 2026-08-05 |
| 2026-03-31 | $330.51M | — | $358.43M | $330.96M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $442.93M | -$29.10M | -$411.58M | -$412.23M | 10-K filed 2026-03-02 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $370.04M | $219.27M | -$103.39M | -$50.57M | 10-K filed 2026-03-02 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-06-30 | $513.12M | $360.56M | $115.58M | $196.89M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-03-31 | $611.52M | $473.96M | -$300.39M | -$447.51M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $658.41M | $505.85M | $161.68M | $159.05M | 10-K filed 2026-03-02 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $429.77M | $338.08M | $22.20M | $33.61M | 10-K filed 2026-03-02 Assembled from more than one filing; the filing above is only the newest of them. |
- Assets
- $3.19B
- Equity
- $1.53B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $1.86B | -$699.78M | -$713.41M | -$307.45M |
| 2024-12-31 | $1.79B | $218.08M | $235.24M | -$342.74M |
| 2023-12-31 | $1.14B | -$267.82M | -$535.98M | -$577.10M |
| 2022-12-31 | $843.77M | -$536.20M | -$703.49M | -$356.17M |
| 2021-12-31 | $612.40M | -$459.71M | -$418.78M | -$481.66M |
| 2020-12-31 | $455.87M | -$564.16M | -$554.13M | $25.26M |
| 2019-12-31 | $380.83M | -$705.56M | -$715.08M | -$516.09M |
| 2018-12-31 | $301.03M | -$343.63M | -$361.92M | -$449.82M |
| 2017-12-31 | $154.58M | -$171.64M | -$50.69M | -$244.00M |
| 2016-12-31 | $5.42M | -$266.73M | -$267.26M | -$251.16M |
Company filings
events
Material agreement
Material agreementSep 238-KResults
ResultsAug 58-KExecutive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureJul 278-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 48-KResults
ResultsMay 68-KExecutive or director change
Executive or director changeFeb 258-K
5% owners ()
AQR Capital Management, LLC
Stake update
STATE STREET CORPORATION
Passive stake
Vanguard Portfolio Management
Stake update
BlackRock, Inc.
Stake update
Vanguard Capital Management
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Bridgewater Associates
Period Tue 30 Jun 2026
0.0%Added - Point72
Period Tue 30 Jun 2026
0.0%New
News
Stories that named SRPT, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about SRPT.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on SRPT come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the SRPT board